Skip to main content
. 2009 Oct;158(1):26–30. doi: 10.1111/j.1365-2249.2009.03987.x

Fig. 3.

Fig. 3

Functional and frequency analysis of regulatory T cells of relapsing–remitting multiple sclerosis (RR-MS) before and after glucocorticoid (GC) treatment. (a) Suppression of carboxyl fluorescein diacetate succinimidyl ester (CFSE)-labelled responder cells from healthy controls (HC) by bead-sorted CD4+CD25+ T cells from HC and MS patients. CFSE histograms from one representative HC and RR-MS patient are shown. (b) Frequencies of CD4+CD25+forkhead box P3 (FoxP3)+ T cells in the peripheral blood of HC, RR-MS and secondary-progressive MS (SP-MS) patients. (c) Frequencies of regulatory T cells with interleukin (IL)-10 secretion.